A scientist–entrepreneur with deep expertise in biocatalysis and microfluidics, Akbar has pioneered systems that enable rapid, close-to-application screening of enzyme variants at unprecedented scale. His work bridges fundamental research and industrial application, accelerating the discovery and optimization of biocatalysts across pharmaceutical, chemical, and emerging biological processes.
As a co-founder of Allozymes, Akbar has been instrumental in translating early scientific breakthroughs into a scalable platform that powers next-generation enzyme engineering. His contributions continue to shape the company’s capabilities in delivering high-performance, application-ready enzymes for real-world manufacturing challenges.
Akbar holds a PhD in Biocatalysis from the National University of Singapore.
作为一名在生物催化和微流控领域拥有深厚专业背景的科学家兼创业者，Akbar 开创了一系列创新技术体系，使酶变体能够以前所未有的规模进行快速且贴近实际应用场景的筛选。他的工作连接了基础研究与工业应用，加速了生物催化剂在制药、化工及新兴生物制造领域的发现与优化。
作为 Allozymes 的联合创始人，Akbar 在将早期科研突破转化为可规模化应用的技术平台方面发挥了重要作用，为新一代酶工程提供有力支撑。他的工作持续推动 Allozymes 技术能力的发展，助力开发高性能、可直接应用于实际生产的酶，以应对现实制造中的各类挑战。
Akbar 拥有新加坡国立大学（National University of Singapore）生物催化博士学位。